HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Percutaneous Microwave Ablation of an Insulinoma in a Patient with Refractory Symptomatic Hypoglycemia.

Abstract
Insulinomas are the most common functioning pancreatic neuroendocrine tumors (pNETs). Surgical excision is the preferred therapy, and medical treatment with diazoxide or octreotide is typically reserved for those who are poor surgical candidates. A recent emergence of minimally invasive treatment modalities has led to reports of successful radiofrequency and ethanol ablation of insulinomas. We report the first use of microwave ablation for treatment of an insulinoma in a patient with medical comorbidities contraindicating surgery.
AuthorsOliver T Chen, Farheen K Dojki, Sharon M Weber, J Louis Hinshaw
JournalJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (J Gastrointest Surg) Vol. 19 Issue 7 Pg. 1378-81 (Jul 2015) ISSN: 1873-4626 [Electronic] United States
PMID25941027 (Publication Type: Case Reports, Journal Article)
Topics
  • Catheter Ablation
  • Humans
  • Hypoglycemia (etiology)
  • Insulinoma (complications, therapy)
  • Male
  • Microwaves (therapeutic use)
  • Middle Aged
  • Pancreatic Neoplasms (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: